Thought Leadership
Email Page
EpiPen Price Increases Were Made Worse by the Fact That You Can’t Buy Just One
September 7, 2016
Emma Court
MarketWatch

Axinn partner Thomas Rohback was quoted in the Market Watch article, "EpiPen Price Increases Were Made Worse by the Fact That You Can’t Buy Just One."

Click here to access the article. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.